Flattening the curve: imperative when China eases the severe COVID-19 control policy.

Zhao, Shilei; Sha, Tong; Xue, Yongbiao; Chen, Hua

Zhao, Shilei; Sha, Tong; Xue, Yongbiao; Chen, Hua.

Zhao S; Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing 100101, China; School of Future Technology and College of Life Science, University of Chinese Academy of Sciences, Beijing 100049, China.
Sha T; Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing 100101, China; School of Future Technology and College of Life Science, University of Chinese Academy of Sciences, Beijing 100049, China.
Xue Y; Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing 100101, China; School of Future Technology and College of Life Science, University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address: ybxue@big.ac.cn.
Chen H; Beijing Institute of Genomics, Chinese Academy of Sciences and China National Center for Bioinformation, Beijing 100101, China; School of Future Technology and College of Life Science, University of Chinese Academy of Sciences, Beijing 100049, China; CAS Center for Excellence in Animal Evolution and

J Infect ; 86(3): e75-e77, 2023 03.

Article in English | MEDLINE | ID: covidwho-2180654

Subject(s)

COVID-19; Humans; COVID-19/prevention & control; SARS-CoV-2; Policy; China/epidemiology

Keywords

COVID-19 pandemic; Flattening curve; Healthcare system

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Observational study Limits: Humans Country/Region as subject: Asia Language: English Journal: J Infect Year: 2023 Document Type: Article Affiliation country: J.jinf.2022.12.022

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google